Novel Coronavirus (COVID-19) News

Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.

Latest

The Centers for Medicare & Medicaid Services updated its FAQs regarding coverage, billing and payment for monoclonal antibody therapies used to treat COVID-19.
The Department of Defense announced a phased plan for the distribution and administration of initial and subsequent COVID-19 vaccine allocations to populations of DoD uniformed service members, including members of the National Guard; dependents; retirees; civilian employees; and select DoD contract personnel as authorized in accordance with agency regulation.
Peer-reviewed data for Pfizer Inc.’s BNT162b2 mRNA COVID-19 vaccine candidate was published by the New England Journal of Medicine, confirming its safety and efficacy.
The Department of Health and Human Services updated its guidance to hospitals on the reporting of COVID-19-related data.
This podcast, in support of AHA’s national strategic alliance with the National Urban League, is bringing attention to health inequities in Black and underserved communities through the lens of the ongoing COVID-19 public health emergency and this year’s flu season.
The AHA urged Congressional leaders to support the bipartisan Healthcare Workforce Resilience Act (H.R. 6788/S.3599), and include it in forthcoming COVID-19 relief legislation.
A bipartisan group of representatives and senators released details on a $908 billion COVID-19 relief bill that they are pushing.  
Over 9,000 eligible nursing homes, or 69%, will receive a portion of $523 million in COVID-19 Provider Relief Funds for meeting infection control and mortality criteria in effect from September through October, the Health Resources and Services Administration announced.
The Centers for Medicare & Medicaid Services updated its guidance on enforcement discretion during the COVID-19 public health emergency for laboratories performing molecular and antigen tests for the virus on asymptomatic individuals at the point of care or in patient care settings operating under a Clinical Laboratory Improvement Amendments certificate.
The Department of Health and Human Services has released hospital-level data on COVID-19 capacity, aggregated by week going back to Aug. 1.
The Centers for Medicare & Medicaid Services Dec. 9 at 4 p.m. ET will host a call to discuss recent flexibilities the agency announced to allow acute health care services to be provided outside of a hospital setting in response to the surging COVID-19 pandemic.
The AHA released a new edition of the COVID-19 Snapshot to impart upon Congress the critical needs of hospitals and health systems during the deepening public health emergency.
The Food and Drug Administration released a briefing document on Pfizer’s BNT162b2 COVID-19 vaccine candidate that confirms the drug maker’s claims of the vaccine’s efficacy and safety.
The Centers for Disease Control and Prevention has published an addenda with instructions for implementing six new ICD-10 diagnosis codes for reporting COVID-19-related conditions on health care claims effective Jan. 1.
The Food and Drug Administration authorized the first prescription diagnostic test for both COVID-19 and influenza A and B that allows patients to collect a sample at home and ship it to a laboratory for analysis.
by Melinda L. Estes, M.D.
Since the COVID-19 pandemic arrived in the U.S. nearly 10 months ago, our hospitals and health systems have learned so much about how to slow down the spread, care for patients and help them recover.
To continue emphasizing the message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns released new resources, including new sample social media messages and graphics that hospitals and health systems can use to reiterate the importance of getting a flu shot, wearing a mask and practicing good hygiene.
The AHA released the latest edition of a new report for Congress to better understand the needs of hospitals and health systems during the public health emergency.
The Centers for Medicare & Medicaid Services has identified the Healthcare Common Procedural Coding System codes and Medicare Part B payment allowances effective Nov. 21 for administering casirivimab and imdevimab, a combination monoclonal antibody therapy made by Regeneron.
The Cybersecurity and Infrastructure Security Agency alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures.